We analyze a patient’s genes and provide personalized information to help physicians select medications that better match their patient’s needs.
Our advanced interpretation is the difference.
OnGenomics assesses genetic variations in patients to help physicians create optimized drug treatment plans.
Pharamcogenomics tests genetic make up – to choose the drug and drug dosage that is appropriate while creating a genetic profile of how a patient’s body metabolizes drugs.
This will identify drugs that will best treat their disease and is least likely to cause side effects. As well as reducing the risk of side effects, another huge advantage of using pharmacogenomics is that it allows for more efficient use of treatments.
For example, some cancer treatments can be very expensive but may only be effective in a small subset of patients. With a better understanding of the disease and the treatment through pharmacogenomics, resources can be focused on treatments that are more likely to be effective in a patient, irrespective of cost.
Common causes of medication errors: incorrect diagnosis, prescribing the wrong medication, drug interactions and reactions, dose miscalculations, incorrect drug administration, lack of patient education and improper training or education.
FDA Estimate of Injury Due to Medication Errors
Preventable Adverse Drug Reaction Costs/Year
Medication Errors in Hospitals
Cardiovascular. Pain. Psychotropic. Cancer Screening.
Prescriptions medications should not be “one-size-fits-all” approach. Our tests help physicians treat knowing the right drug with the right dose.
The FDA recommends genetic testing for many types of drugs commonly prescribed for cardiovascular conditions to best determine therapy regimens. Our cardiology genetic panel allows for drug optimization as well as risk assessment for Thromophilia, Hyperhomocysteinemia and Hyperlipidemia / Atherosclerotic Vascular disease. Learn more…
Now physicians have a guide to medication decisions for those with acute or chronic pain using patients’ own genetic profiles to help determine their potential response across four relevant medication classes: opioids, NSAIDs, muscle relaxants, and opioid dependency. Learn more…
These are commonly prescribed to treat depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder, obsessive compulsive disorder, schizophrenia or other behavioral health conditions. Learn more…
Cancer screening are vital in increasing the chances of detecting certain cancers early. Our tests include BRCA1/2: breast cancer and ovarian cancer. Also, hereditary colon and rectal cancers – Lynch Syndrome – mutations in these highly penetrant genes cause increased risk for cancers of the colon, uterus, stomach and ovaries. Learn more…
Why does OnGenomics’ tests makes clinical sense?
Most medications are metabolized, (broken down) through the liver. This process can vary from person to person and either be too quick in some, or too slow in others. It is estimated that more than 75% of the population have variations in their genetic makeup of drug metabolism. Therefore, this test will help your doctor choose the proper medication at the appropriate dose for you.
For example, two people can take the same medication at the same dosages, but react very differently from one another. The medication could work very well in one, but not other, and while one individual may experience side effects, the other may not.
With the high level of accuracy and specificity this test provides, your doctor will no longer have to rely on the old “trial and error” method when prescribing you a medication.
THE ONGENOMICS™ DIFFERENCE
OnGenomics™ utilizes only CLIA and CAP certified labs that specializes in Pharmacogenomics Testing, Genetic Carrier Screening and Cancer Screening.
Our comprehensive team is made of board certified pathologists, pharmacists , molecular geneticists, and oncologists who have completed their training from prestigious institutions such as Baylor College of Medicine, University of California, and UT MD Anderson Cancer Center.